Journal of Chinese Pharmaceutical Sciences ›› 2023, Vol. 32 ›› Issue (5): 379-391.DOI: 10.5246/jcps.2023.05.032
• Original articles • Previous Articles Next Articles
Guangzhi Shen1, Xingang Cui2, Zhimin Na3, Yulong Zou4,*(), Guihua Zou1,*(
)
Received:
2022-10-28
Revised:
2022-11-15
Accepted:
2022-12-18
Online:
2023-06-02
Published:
2023-06-02
Contact:
Yulong Zou, Guihua Zou
Supporting:
Guangzhi Shen, Xingang Cui, Zhimin Na, Yulong Zou, Guihua Zou. A network pharmacology approach to explore the pharmacological mechanism of Epimedium brevicornum in sexual dysfunction[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 379-391.
[1] |
Li, S.; Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin. J. Nat. Med. 2013, 11, 110–120.
|
[2] |
Gao, L.; Wang, X.D.; Niu, Y.Y.; Duan, D.D.; Yang, X.; Hao, J.; Zhu, C.H.; Chen, D.; Wang, K.X.; Qin, X.M.; Wu, X.Z. Molecular targets of Chinese herbs: a clinical study of hepatoma based on network pharmacology. Sci. Rep. 2016, 6, 24944.
|
[3] |
Park, H.J.; Koo, Y.K.; Park, M.J.; Hwang, Y.K.; Hwang, S.Y.; Park, N.C. Restoration of spermatogenesis using a new combined herbal formula of epimedium koreanum nakai and angelica gigas nakai in an luteinizing hormone-releasing hormone agonist-induced rat model of male infertility. World J. Men’s Heal. 2017, 35, 170–177.
|
[4] |
Zheng, H.; He, B.; Wu, T.X.; Cai, J.; Wei, J.S. Extraction, purification and anti-osteoporotic activity of a polysaccharide from epimedium brevicornum maxim. in vitro. Int. J. Biol. Macromol. 2020, 156, 1135–1145.
|
[5] |
Sze, S.C.; Tong, Y.; Ng, T.B.; Cheng, C.L.; Cheung, H.P. Herba Epimedii: anti-oxidative properties and its medical implications. Molecules. 2010, 15, 7861–7870.
|
[6] |
Yan, F.F.; Liu, Y.; Liu, Y.F.; Zhao, Y.X. Herba Epimedii water extract elevates estrogen level and improves lipid metabolism in postmenopausal women. Phytother. Res. 2008, 22, 1224–1228.
|
[7] |
Zhao, H.; Shan, Y.; Ma, Z.; Yu, M.; Gong, B. A network pharmacology approach to explore active compounds and pharmacological mechanisms of epimedium for treatment of premature ovarian insufficiency. Drug Des. Devel. Ther. 2019, 13, 2997–3007.
|
[8] |
He, J.; Zang, S.L.; Liu, N.; Ji, M.; Ma, D.X.; Ji, C.Y. Epimedium polysaccharides attenuates hematotoxicity by reducing oxidative stress and enhancing immune function in mice model of benzene-induced bone marrow failure. Biomed. Pharmacother. 2020, 125, 109908.
|
[9] |
Shui, Y.M.; Lv, G.Y.; Shan, L.T.; Fan, C.L.; Tian, N.; Zhang, L.; He, T.C.; Gao, J.L. Epimedin C promotes vascularization during BMP2-induced osteogenesis and tumor-associated angiogenesis. Am. J. Chin. Med. 2017, 45, 1093–1111.
|
[10] |
Wang, L.; Li, Y.; Guo, Y.; Ma, R.; Fu, M.; Niu, J.; Gao, S.; Zhang, D. Herba epimedii: an ancient Chinese herbal medicine in the prevention and treatment of osteoporosis. Curr. Pharm. Des. 2016, 22, 328–349.
|
[11] |
Pan, Y.; Kong, L.D.; Li, Y.C.; Xia, X.; Kung, H.F.; Jiang, F.X. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol. Biochem. Behav. 2007, 87, 130–140.
|
[12] |
Chen, G.; Wang, C.; Wang, J.; Yin, S.; Gao, H.; Xiang, L.U.; Liu, H.; Xiong, Y.; Wang, P.; Zhu, X.; Yang, L.I.; Zhang, R. Antiosteoporotic effect of icariin in ovariectomized rats is mediated via the Wnt/β-catenin pathway. Exp. Ther. Med. 2016, 12, 279–287.
|
[13] |
Wang, G.Q.; Li, D.D.; Huang, C.; Lu, D.S.; Zhang, C.; Zhou, S.Y.; Liu, J.; Zhang, F. Icariin reduces dopaminergic neuronal loss and microglia-mediated inflammation in vivo and in vitro. Front. Mol. Neurosci. 2017, 10, 441.
|
[14] |
Wei, Z.; Deng, X.; Hong, M.; Su, Q.; Liu, A.; Huang, Y.; Yu, Q.; Peng, Z. Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects. Int. J. Clin. Exp. Med. 2015, 8, 20188–20197.
|
[15] |
Geerkens, M.J.M.; Al-Itejawi, H.H.M.; Nieuwenhuijzen, J.A.; Meuleman, E.J.M.; Lissenberg-Witte, B.I.; van Moorselaar R.J.A.; Vis, A.N. Sexual dysfunction and bother due to erectile dysfunction in the healthy elderly male population: prevalence from a systematic review. Eur. Urol. Focus. 2020, 6, 776–790.
|
[16] |
Zhang, Y.; Zhang, Q.; Shi, Z.Y.; Chen, H.X.; Wang, J.C.; Yan, C.; Du, Q.; Qiu, Y.H.; Zhao, Z.Y.; Zhou, H.Y. Sexual dysfunction in patients with neuromyelitis optica spectrum disorder. J. Neuroimmunol. 2020, 338, 577093.
|
[17] |
McCabe, M.P. Risk factors for sexual dysfunction among women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J. Sex. Med. 2016, 13, 153–167.
|
[18] |
Wang, Y.; Yu, W.; Shi, C.; Jiao, W.; Li, J.; Ge, J.; Hong, Y.; Shi, G. Network pharmacology of yougui pill combined with buzhong Yiqi Decoction for the treatment of sexual dysfunction. Evid. Based. Complement. Altern. Med. 2019, 2019, 1243743.
|
[19] |
Hatzimouratidis, K.; Amar, E.; Eardley, I.; Giuliano F.; Hatzichristou, D.; Montorsi, F.; Vardi, Y.; Wespes, E. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur. Urol. 2010, 57, 804–814.
|
[20] |
Porst, H.; Montorsi, F.; Rosen, R.C.; Gaynor, L.; Grupe, S.; Alexander, J. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur. Urol. 2007, 51, 816–824.
|
[21] |
Finkelstein, F.O.; Shirani, S.; Wuerth, D.; Finkelstein, S.H. Therapy Insight: sexual dysfunction in patients with chronic kidney disease. Nat. Clin. Pract. Nephrol. 2007, 3, 200–207.
|
[22] |
Soldati, L.; Bianchi-Demicheli, F.; Schockaert, P.; Köhl, J.; Bolmont, M.; Hasler, R.; Perroud, N. Sexual function, sexual dysfunctions, and ADHD: a systematic literature review. J. Sex. Med. 2020, 17, 1653–1664.
|
[23] |
Hopkins, A.L. Network pharmacology. Nat. Biotechnol. 2007, 25, 1110–1111.
|
[24] |
Xie, W.W.; Wen, X.Q.; Zhang, D.D.; Zhang, Y.Q.; Zhang, Z.Q.; Jin, Y.R.; Du, Y.F. Network pharmacology-based strategy to investigate harmacological mechanisms of Isodon serra (Maxim.) Hara for treatment of inflammatory. J. Chin. Pharm. Sci. 2022, 31, 250–263.
|
[25] |
Zeng, L.T.; Yang, K.L.; Ge, J.W. Uncovering the pharmacological mechanism of astragalus salvia compound on pregnancy-induced hypertension syndrome by a network pharmacology approach. Sci. Rep. 2017, 7, 16849.
|
[26] |
Zhang, Y.Q.; Guo, X.D.; Wang, D.H.; Li, R.S.; Li, X.J.; Xu, Y.; Liu, Z.L.; Song, Z.Q.; Lin, Y.; Li, Z.Y.; Lin, N. A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma. Sci. Rep. 2014, 4, 4154.
|
[27] |
Kochmann, S. Beryllium10: a free and simple tool for creating and managing group safety data sheets. J. Pharmacol. Sci. 2014, 6, 6.
|
[28] |
Tang, H.; He, S.; Zhang, X.; Luo, S.; Zhang, B.; Duan, X.; Zhang, Z.; Wang, W.; Wang, Y.; Sun, Y. A network pharmacology approach to uncover the pharmacological mechanism of XuanHuSuo Powder on osteoarthritis. Evid. Based Complement. Altern. Med. 2016, 2016, 3246946.
|
[29] |
Amberger, J.S.; Bocchini, C.A.; Schiettecatte, F.; Scott, A.F.; Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015, 43, D789–D798.
|
[30] |
Stelzer, G.; Dalah, I.; Stein, T.I.; Satanower, Y.; Rosen, N.; Nativ, N.; Oz-Levi, D.; Olender, T.; Belinky, F.; Bahir, I.; Krug, H.; Perco, P.; Mayer, B.; Kolker, E.; Safran, M.; Lancet, D. In-silico human genomics with GeneCards. Hum. Genom. 2011, 5, 709–717.
|
[31] |
Vlachopoulos, C.; Aznaouridis, K.; Ioakeimidis, N.; Rokkas, K.; Vasiliadou, C.; Alexopoulos, N.; Stefanadi, E.; Askitis, A.; Stefanadis, C. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur. Heart J. 2006, 27, 2640–2648.
|
[32] |
Libro, R.; Bramanti, P.; Mazzon, E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci. 2016, 158, 78–88.
|
[33] |
Vignozzi, L. Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. J. Sex. Med. 2014, 11, 2890–2902.
|
[34] |
Sargent, K.M.; Clopton, D.T.; Lu, N.; Pohlmeier, W.E.; Cupp, A.S. VEGFA splicing: divergent isoforms regulate spermatogonial stem cell maintenance. Cell Tissue Res. 2016, 363, 31–45.
|
[35] |
Shirai, M.; Yamanaka, M.; Shiina, H.; Igawa, M.; Ogishima, T.; Fujime, M.; Ishii, N.; Okuyama, A.; Lue, T.F.; Dahiya, R. Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment. Urology. 2004, 64, 1244–1249.
|
[36] |
Giuliano, F.; Allard, J. Dopamine and male sexual function. Eur. Urol. 2001, 40, 601–608.
|
[37] |
Eldamnhoury, E.M.; Elatrash, G.A.; Rashwan, H.M.; El-Sakka, A.I. Association between leukocytospermia and semen interleukin-6 and tumor necrosis factor-alpha in infertile men. Andrology. 2018, 6, 775–780.
|
[38] |
Wu, L.; Wang, Y.; Nie, J.; Fan, X.; Cheng, Y. A network pharmacology approach to evaluating the efficacy of Chinese medicine using genome-wide transcriptional expression data. Evid. Based Complement. Altern. Med. 2013, 2013, 915343.
|
[1] | Mengyao Wu, Lu Liu, Peng Zhang, Lele Zhang, Yun Gong, Xiuwei Yang. Exploring the mechanism of Buxue Yimu Pills on postpartum abdominal pain through network pharmacology and experimental validation [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 691-703. |
[2] | Ping Shang, Lin Liu, Yi Fang. Investigating the mechanism of action of Gui Zhi Fu Ling Wan in the treatment of endometriosis based on network pharmacology and molecular docking [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 704-719. |
[3] | Gedi Zhang, Gengxin Liu, Ziyou Yan. Therapeutic efficacy evaluation and mechanism of action based on meta-analysis and network pharmacology of Li Chong Decoction (Bolus) for cancer treatment [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 720-735. |
[4] | Dongyan Wu, Xiaodan Wang, Jinmiao Chai, Qinqing Li, Yue Li, Mei Bi, Wanwei Gui, Huimin Cao. Study on the mechanism of Danggui Buxue decoction in the treatment of diabetic retinopathy based on network pharmacology and experiment [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(7): 527-538. |
[5] | Huan Yan, Jian Wang, Hao Fu, Min Yang, Miao Qu, Zhie Fang. Discussion on the potential target and mechanism of Dachaihu Decoction in treating hyperlipidemia based on network pharmacology [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(6): 446-459. |
[6] | Mengya Wang, Kuanyou Zhang, Xin Chen, Hao Fu, Shouchun Peng. Study on the mechanism of Rhinoceros Horn and Rehmannia Decoction in the treatment of systemic lupus erythematosus based on the method of network pharmacology [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(5): 351-359. |
[7] | Min Ao, Minglan Bao, Yaxing Hou, Ying Yue, Huifang Li, Guohua Wu, Su Ri Ga La Tu. Study on the mechanism of Mongolian medicine Herba Lomatognii against acute liver injury based on network pharmacology [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(4): 268-282. |
[8] | Yajing Li, Yawen Bai, Yu Du, Changhong Yan, Chunjie Ma, Lining Sun, Fengyue Bu, Haoyang Yan. Yu Ping Feng Powder for chronic glomerulonephritis treatment: A meta-analysis and network pharmacology study [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(12): 1006-1026. |
[9] | Zhiyong Sun, Shuli Gao, Yang Zhang, Gangqiang Xue, Zilin Yuan, Shaonan Wang. Study on the potential mechanism of Pu Gong Ying in treating breast hyperplasia based on network pharmacology and molecular docking [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 893-910. |
[10] | Yuqian Zhang, Haiying Niu, Yiran Jin. Network pharmacology-based strategy to investigate anticancer mechanisms of Catharanthus roseus (L.) G. Don [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 911-922. |
[11] | Daiying Zhou, Jing Chen, Zhigang Lv. Network pharmacology prediction and molecular docking-based study on the mechanism of Erigeron breviscapus in the treatment of age-related macular degeneratio [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(11): 923-934. |
[12] | Dongsheng Wei, Xiaosheng Liu, Luzhen Li, Jiajie Qi, Yuxuan Wang, Zhe Zhang. Unraveling the biological and immunological mechanisms of safflower-danshen in the treatment of coronary atherosclerotic heart disease: a comprehensive bioinformatics and single-cell sequencing approach [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(10): 796-812. |
[13] | Ning Ding, Tao Zhang, Ji Luo, Haochen Liu, Yu Deng, Yongheng He. Study on the mechanism of Baishao Qiwu Decoction in the treatment of colorectal cancer based on network pharmacology and molecular docking [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(1): 17-31. |
[14] | Ipargul Hafiz, Zhaozhi Wang, Hongji He, Zhezhe Li, Mei Wang. Exploring the mechanism of Peganum harmala L. seeds on hepatocellular carcinoma based on network pharmacology and molecular docking [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(7): 517-529. |
[15] | Weiping Zhao, Qi Ge, Zijun Ding, Leizhi Pan, Ziqing Gu, Yang Liu, Hua Cai. Network pharmacology and metabolomics-based detection of the potential pharmacological effects of the active components in Chrysanthemum morifolium 'Chuju' [J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(6): 412-428. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||